Tetracycline Actions Relevant to Rosacea Treatment

被引:56
|
作者
Korting, H. C. [1 ]
Schoellmann, C. [1 ]
机构
[1] Univ Munich, Dept Dermatol & Allergol, DE-80337 Munich, Germany
关键词
Rosacea; Tetracyclines; Doxycycline; Inflammation; Matrix metalloproteinases; Cytokines; Reactive oxygen species; Angiogenesis; SUBANTIMICROBIAL-DOSE DOXYCYCLINE; CHEMICALLY-MODIFIED TETRACYCLINES; RANDOMIZED PHASE-III; DEMODEX-FOLLICULORUM; OCULAR ROSACEA; NITRIC-OXIDE; MATRIX METALLOPROTEINASES; CHRONIC PERIODONTITIS; TOPICAL THERAPIES; GINGIVAL TISSUE;
D O I
10.1159/000235550
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Until today, the pathogenesis of rosacea is not known in detail. Yet in recent years evidence has been accumulating that rosacea with its common symptoms such as inflammatory lesions, erythema, telangiectasia, phymatous changes, and ocular symptoms is of inflammatory nature. Tetracycline derivatives like doxycycline successfully used in the treatment of skin diseases like acne and rosacea seem to inhibit different inflammatory pathways involved in the pathogenesis by various modes of action. Although data for skin diseases are relatively scanty, the following modes of action of tetracyclines seem to be most relevant for an effective treatment of acne and rosacea: inhibition of matrix metalloproteinases, downmodulation of cytokines, inhibition of cell movement and proliferation, inhibition of granuloma formation, inhibition of reactive oxygen species, nitric oxide, and angiogenesis, whereas inhibition of phospholipase A2 seems to be of lower importance. The role of the saprophytic mite Demodex folliculorum remains to be clarified. Additional studies are necessary to further elucidate how tetracyclines work in rosacea treatment. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:287 / 294
页数:8
相关论文
共 50 条
  • [1] Treatment of rosacea
    Parodi, A.
    Drago, F.
    Paolino, S.
    Cozzani, E.
    Gallo, R.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2011, 138 : S158 - S162
  • [2] Current topical and systemic approaches to treatment of rosacea
    Korting, H. C.
    Schoellmann, C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (08) : 876 - 882
  • [3] Propranolol, doxycycline and combination therapy for the treatment of rosacea
    Park, Jung-Min
    Mun, Je-Ho
    Song, Margaret
    Kim, Hoon-Soo
    Kim, Byung-Soo
    Kim, Moon-Bum
    Ko, Hyun-Chang
    JOURNAL OF DERMATOLOGY, 2015, 42 (01) : 64 - 69
  • [4] Treatment of rosacea with upadacitinib and abrocitinib: case report and review of evidence for Janus kinase inhibition in rosacea
    Zhang, Ting
    Liu, Xu
    Zhang, Lu
    Jiang, Xian
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [5] A Review of the Current Modalities for the Treatment of Papulopustular Rosacea
    McGregor, Sean P.
    Alinia, Hossein
    Snyder, Alyson
    Tuchayi, Sara Moradi
    Fleischer, Alan, Jr.
    Feldman, Steven R.
    DERMATOLOGIC CLINICS, 2018, 36 (02) : 135 - +
  • [6] Practice Patterns and Clinician Opinions for Treatment of Ocular Rosacea
    Kaur, Gurbani
    Redd, Travis K.
    Seitzman, Gerami D.
    CORNEA, 2023, 42 (11) : 1349 - 1354
  • [7] Rosacea Treatment: Review and Update
    Hanlin Zhang
    Keyun Tang
    Yuchen Wang
    Rouyu Fang
    Qiuning Sun
    Dermatology and Therapy, 2021, 11 : 13 - 24
  • [8] Rosacea Treatment: Review and Update
    Zhang, Hanlin
    Tang, Keyun
    Wang, Yuchen
    Fang, Rouyu
    Sun, Qiuning
    DERMATOLOGY AND THERAPY, 2021, 11 (01) : 13 - 24
  • [9] Emerging Treatment Options for Rosacea
    Naik, Piyu Parth
    CURRENT DERMATOLOGY REPORTS, 2021, 10 (04) : 243 - 253
  • [10] Rosacea Part II. Topical and systemic therapies in the treatment of rosacea
    Two, Aimee M.
    Wu, Wiggin
    Gallo, Richard L.
    Hata, Tissa R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : 761 - 770